DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Clinical trial NCT00397579 · COMPLETED
Trial details
- NCT number
- NCT00397579
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2017-07-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.